J CANCER RES CLIN 润色咨询

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

出版年份：1979 年文章数：3146 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2024-01-19 ms3000000321226977

    偏重的研究方向：肿瘤
    经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见

    13

    展开13条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2024-01-25 ms6000001259041667 来自北京

    偏重的研究方向：肿瘤
    经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊

    13

    展开13条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2023-09-13 ms8000001459205604 来自广西

    一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？

    13

    展开13条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-10-20 xujinjing

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤;代谢;综述
    经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted

    13

    展开13条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2023-12-13 究极奥美拉唑 来自广西

    审稿速度:6.0 | 投稿命中率:75.0
    偏重的研究方向：肿瘤;生信加细胞功能实验
    经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！
    Submission is in publishing and rights
    12 Dec 2023
    Peer review
    Submission status Date
    Submission accepted
    12 Dec 2023
    Submission under peer review
    06 Dec 2023
    Submission passed technical check
    06 Dec 2023
    Revision received
    03 Dec 2023
    Submission under peer review
    15 Nov 2023
    Submission passed technical check
    15 Nov 2023
    Revision received
    14 Nov 2023
    Submission under peer review
    05 Sep 2023
    Submission passed technical check
    05 Sep 2023
    Revision received
    04 Sep 2023
    Submission under peer review
    05 Aug 2023
    Technical check
    Submission status Date
    Submission passed technical check
    05 Aug 2023
    Submission is under technical check
    04 Aug 2023
    Submission received
    Submission status Date
    Submission received
    04 Aug 2023

    12

    展开12条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2023-08-04 ms1000001224469901 来自河南省

    审稿速度:1.0 | 投稿命中率:95.0
    经验分享：2023.07.13投稿
    2023.07.23返修
    2023.07.26上传返修稿
    2023.08.04接受，整个过程20天，效率极高的杂志。

    12

    展开12条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2023-05-04 ms6000001537745536 来自四川省

    五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了

    12

    展开12条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-01-07 bb1991

    under review半个月之后变成editor assigned会不会马上被拒😢

    12

    展开12条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2023-07-25 ms4000001131300035 来自四川省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂

    12

    展开12条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤<br>经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向：肿瘤<br>经验分享：1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2094974, encodeId=0b5720949e4fd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;代谢;综述<br>经验分享：在梅斯获得了很多帮助。大家的经验分享在我等待结果的过程中给了我很多借鉴和宽慰。现在文章接收了，也来跟大家分享一下，希望对大家有用。9.9 ffirst submitted; 9.10submission checks complete; 9.11 editor assigned; 9.11 reviewers invited; 9.14 reviewers agreed; 9.16 reviewers received; 9.21 Major revision; 10.07 submitted to joural; 10.8 submission checks complete; 10.8 reviewers invited; 10.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51041942628, createdName=xujinjing, createdTime=Thu Oct 20 15:24:57 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤;生信加细胞功能实验<br>经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！<br>Submission is in publishing and rights<br>12 Dec 2023<br>Peer review<br>Submission status Date<br>Submission accepted<br>12 Dec 2023<br>Submission under peer review<br>06 Dec 2023<br>Submission passed technical check<br>06 Dec 2023<br>Revision received<br>03 Dec 2023<br>Submission under peer review<br>15 Nov 2023<br>Submission passed technical check<br>15 Nov 2023<br>Revision received<br>14 Nov 2023<br>Submission under peer review<br>05 Sep 2023<br>Submission passed technical check<br>05 Sep 2023<br>Revision received<br>04 Sep 2023<br>Submission under peer review<br>05 Aug 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>05 Aug 2023<br>Submission is under technical check<br>04 Aug 2023<br>Submission received<br>Submission status Date<br>Submission received<br>04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：2023.07.13投稿<br>2023.07.23返修<br>2023.07.26上传返修稿<br>2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130113, encodeId=f694213011372, content=五月三日投稿 五月四日under review 一个审稿人已经接受了审稿 不管中不中 这本杂志在我心里都是神刊了 处理效率太高了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Thu May 04 21:09:17 CST 2023, time=2023-05-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1181757, encodeId=71721181e576b, content=under review半个月之后变成editor assigned会不会马上被拒😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C02582FFE6A6A643ED464CAAEA0FFEED/100, createdBy=208a2400613, createdName=bb1991, createdTime=Fri Jan 07 09:52:10 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1228452, encodeId=5e94122845256, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;眼科<br>经验分享：<br><br>审稿流程分享，希望能帮到大家<br>2022-5-5 Submitted to Journal <br>2022-5-6 Quality check passed<br>2022-5-10 1 Reviewer(s) accepted<br>2022-5-14 2 Reviewer(s) accepted<br>2022-5-24 1 Reviewer report received<br>2022-6-1 Reviewer reports received / Ready for editor’s decision<br>2022-6-3 Revision requested<br>2022-6-14 Revision submitted <br>2022-6-16 Editor evaluating revision <br>2022-6-16 1 Reviewer report received<br>2022-6-17 Submission has been accepted<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Fri Jun 24 15:49:44 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-06-24 18344b9fa1m

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤;眼科
    经验分享：

    审稿流程分享，希望能帮到大家
    2022-5-5 Submitted to Journal
    2022-5-6 Quality check passed
    2022-5-10 1 Reviewer(s) accepted
    2022-5-14 2 Reviewer(s) accepted
    2022-5-24 1 Reviewer report received
    2022-6-1 Reviewer reports received / Ready for editor’s decision
    2022-6-3 Revision requested
    2022-6-14 Revision submitted
    2022-6-16 Editor evaluating revision
    2022-6-16 1 Reviewer report received
    2022-6-17 Submission has been accepted

    12

    展开12条回复
共500条页码: 3/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分